secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001023024-24-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals shareholders approve Amended 2022 Stock Plan, re-elect directors
--------------------------------------------------------------------------------

- At May 21 annual meeting, all eight director nominees elected; Thomas Haughey received 14.8M for, 2.1M against.
- Shareholders ratified EisnerAmper as auditor for FY2024: 18.0M for, 56.7K against.
- Advisory say-on-pay approved: 16.1M for, 762.7K against, 1.2M broker non-votes.
- Amended 2022 Stock Incentive Plan approved: 16.0M for, 871.2K against, 1.2M broker non-votes.
- Plan increases equity pool; forms for director (1-yr cliff) and employee (4-yr graded) restricted stock filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000063/0001023024-24-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000063/ani-20240521.htm
  HTML page:      https://secwatch.observer/filing/0001023024-24-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer